scholarly journals Asymptomatic Hemangioma of the Duodenum

Author(s):  
Tristan Thomas ◽  
Michael Haney ◽  
Matthew Doepker

Hemangiomas of the small bowel are exceedingly rare benign tumors. When diagnosed they are found in the setting of an acute gastrointestinal bleeding, but can also be involved in intussusception, obstruction, and cause pain. There are few reports of this case over all, and incidental or asymptomatic cases are rare for adult patients. Although computed tomography with angiography or tagged red blood cell scans are pivotal for acute active bleeding, endoscopy has become pivotal in diagnosis of lesions that are quiescent. Management is also variable as endoscopy, laparoscopy, and open surgery have all been utilized with success.

2019 ◽  
Vol 92 (1094) ◽  
pp. 20180336
Author(s):  
Ram Kishore Gurajala ◽  
Ehsan Fayazzadeh ◽  
Elie Nasr ◽  
Sankaran Shrikanthan ◽  
Shyam Srinivas ◽  
...  

2020 ◽  
Author(s):  
Zhu Wang ◽  
Ya-Wen Xie ◽  
Qing Lu ◽  
Hai-Lin Yan ◽  
Xin-Bin Liu ◽  
...  

Abstract BackgroundTo investigate the effect of albumin infusion in cirrhotic patients admitted for acute gastrointestinal bleeding.MethodsMedical records of cirrhotic patients who admitted due to acute gastrointestinal bleeding through January 2009 to December 2018 were systemically reviewed. Clinical data and the total amount of albumin and red blood cell used during hospitalization were recorded. For patients with rebleeding, the amount of albumin and red blood cell used before rebleeding was also documented. The primary outcome was the occurrence of rebleeding and the second outcome was in-hospital mortality. Univariate and multivariate logistic analysis were performed to identify risk factors associated with rebleeding and in-hospital mortality.ResultsA total of 2239 cirrhotic patients were included in the analysis. There were 245 episodes of in-patient rebleeding occurred, while 135 patients died. Overall, more red blood cells and albumin were prescribed to patients who suffered rebleeding. In terms of the amount before rebleeding, the red blood cell was higher in patients with rebleeding, but the albumin infusion were similar. In the multivariate model, the albumin infusion was an independent risk factor associated with rebleeding (adjusted OR for ≤40g, 0.385 [0.252-0.588], p<0.001; OR for >40g, 0.295 [0.169-0.514], p<0.001). The use of albumin more than 40g during hospitalization reduces the risk of in-patient mortality (adjusted OR for ≤40g, 0.730 [0.375-1.423], p=0.356; OR for >40g, 0.389 [0.180-0.838], p=0.016).ConclusionsAlbumin infusion could reduce risk of in-hospital rebleeding. Moreover, more than 40g albumin infusion decrease numbers of mortality in cirrhosis admitted for acute gastrointestinal bleeding.


2020 ◽  
Author(s):  
Zhu Wang ◽  
Ya-Wen Xie ◽  
Qing Lu ◽  
Hai-Lin Yan ◽  
Xin-Bin Liu ◽  
...  

Abstract Background: To investigate the effect of albumin infusion on cirrhotic patients admitted for acute gastrointestinal bleeding. Methods: Medical records of cirrhotic patients who admitted due to acute gastrointestinal bleeding through January 2009 to December 2018 were systemically reviewed. Clinical data and the total amount of albumin and red blood cell used during hospitalization were recorded. For patients with rebleeding, the amount of albumin and red blood cell used before rebleeding was also documented. The primary outcome was the occurrence of rebleeding, and the second outcome was in-hospital mortality. Univariate and multivariate logistic analysis was performed to identify risk factors associated with rebleeding and in-hospital mortality. Results: A total of 2239 cirrhotic patients were included in the analysis. There were 245 episodes of in-patient rebleeding occurred, while 135 patients died. Overall, more red blood cells and albumin were prescribed to patients who suffered rebleeding. In terms of the amount before rebleeding, the red blood cell was higher in patients with rebleeding, but the albumin infusion was similar. In the multivariate model, the albumin infusion was an independent risk factor associated with rebleeding (adjusted OR for ≤40g, 0.385 [0.252-0.588], p<0.001; OR for >40g, 0.295 [0.169-0.514], p<0.001). The use of albumin more than 40g during hospitalization associated with a lower risk of in-patient mortality (adjusted OR for ≤40g, 0.730[0.375-1.423] , p=0.356; OR for >40g, 0.389 [0.180-0.838], p=0.016). Conclusions: Albumin infusion was associated with a lower risk of rebleeding and in-hospital deaths in cirrhosis admitted for acute gastrointestinal bleeding.


2020 ◽  
Author(s):  
Zhu Wang ◽  
Ya-Wen Xie ◽  
Qing Lu ◽  
Hai-Lin Yan ◽  
Xin-Bin Liu ◽  
...  

Abstract Background: To investigate the effect of albumin infusion on cirrhotic patients admitted for acute gastrointestinal bleeding.Methods: Medical records of cirrhotic patients who admitted due to acute gastrointestinal bleeding through January 2009 to December 2018 were reviewed. Clinical data and the total amount of albumin and red blood cell used during hospitalization were recorded. For patients with rebleeding, the amount of albumin and red blood cell used before rebleeding was also documented. The primary outcome was the occurrence of rebleeding, and the second outcome was in-hospital mortality. Univariate and multivariate logistic analysis was performed to identify risk factors associated with rebleeding and in-hospital mortality.Results: A total of 1503 cirrhotic patients were included in the analysis. There were 146 episodes of in-patient rebleeding occurred, while 81 patients died. Overall, more red blood cells and albumin were prescribed to patients who suffered rebleeding. In terms of the amount before rebleeding, the red blood cell was higher in patients with rebleeding, but the albumin infusion was similar. In the multivariate model, the albumin infusion was an independent risk factor associated with rebleeding (adjusted OR for ≤40g vs 0g, 0.469 [0.274-0.805], p=0.006; adjusted OR for >40g vs 0g, 0.272 [0.122-0.604], p=0.001). In Child-Pugh C class patients, the use of albumin more than 40g during hospitalization associated with a lower risk of in-patient mortality (adjusted OR for >40g vs 0g, 0.136 [0.019-0.741], p=0.031).Conclusions: Albumin infusion was associated with a lower risk of rebleeding and in-hospital deaths in cirrhosis admitted for acute gastrointestinal bleeding.


2018 ◽  
Vol 1 (2) ◽  
Author(s):  
Ade Mayashita ◽  
Ahmad Asmedi ◽  
Tommy Rachmat ◽  
Siti Farida

Latar Belakang: Stroke iskemik menyebabkan terjadinya inflamasi sel. Sitokin inflamasi menyebabkan peningkatan Red-Blood-Cell Distribution Width (RDW) dan mencegah maturasi sel darah merah. Pemeriksaan RDW rutin dan murah dikerjakan, sehingga diharapkan dapat digunakan sebagai prediksi keparahan klinis pada pasien stroke. Tujuan: Untuk mengetahui hubungan RDW terhadap skor National Institutes of Health Stroke Scale (NIHSS) pasien stroke iskemik akut di Unit Stroke Rumah Sakit Umum Pusat (RSUP) Dr. Sardjito Yogyakarta. Metode Penelitian: Studi dengan rancangan potong lintang. Subjek penelitian adalah pasien stroke iskemik yang dirawat di Unit Stroke RSUP Dr. Sardjito periode Januari 2014 hingga Desember 2015. Diagnosis stroke iskemik akut ditegakkan berdasarkan anamnesis, pemeriksaan fisik, dan pemeriksaan Computed Tomography (CT)-scan kepala. Data NIHSS dan RDW diambil saat admisi dan diuji korelasi dengan tes Pearson. Nilai p<0,05 dianggap signifikan secara statistik. Hasil: Sebanyak 51 orang subjek dimasukkan dalam penelitian. Hasil analisis menunjukkan bahwa RDW serum berkorelasi terhadap NIHSS (r= 0,296; p=0,035).Simpulan: Terdapat korelasi positif antara kadar RDW dengan nilai NIHSS pada penderita stroke iskemik akut dengan kekuatan korelasi rendah, sehingga semakin tinggi kadar RDW, maka semakin tinggi nilai NIHSS.


1989 ◽  
Vol 76 (4) ◽  
pp. 358-361 ◽  
Author(s):  
M. L. Nicholson ◽  
J. P. Neoptolemos ◽  
J. F. Sharp ◽  
E. M. Watkin ◽  
D. P. Fossard

Sign in / Sign up

Export Citation Format

Share Document